515120 创新药ETF
已收盘 08-08 14:59:59
资讯
新帖
简况
【ETF动向】8月8日广发中证香港创新药ETF(QDII)基金跌1.33%,份额增加3.8亿份
证券之星 · 08-08 22:30
【ETF动向】8月8日广发中证香港创新药ETF(QDII)基金跌1.33%,份额增加3.8亿份
ETF收评 | A股再创阶段新高,稀土板块爆发,稀土ETF易方达、稀土ETF涨超3%
格隆汇 · 08-07 07:11
ETF收评 | A股再创阶段新高,稀土板块爆发,稀土ETF易方达、稀土ETF涨超3%
ETF收盘|各ETF跌多涨少 港股通创新药ETF工银跌逾3.06%
市场透视 · 08-07 07:05
ETF收盘|各ETF跌多涨少 港股通创新药ETF工银跌逾3.06%
【ETF动向】8月6日广发中证香港创新药ETF(QDII)基金涨0.75%,份额增加1.38亿份
证券之星 · 08-06 22:30
【ETF动向】8月6日广发中证香港创新药ETF(QDII)基金涨0.75%,份额增加1.38亿份
ETF收评 | 港股创新药板块全天强势,港股创新药ETF、恒生创新药ETF涨3%
格隆汇 · 08-05
ETF收评 | 港股创新药板块全天强势,港股创新药ETF、恒生创新药ETF涨3%
ETF午评 | 隔夜美股收涨,纳指科技ETF涨超2%
格隆汇 · 08-05
ETF午评 | 隔夜美股收涨,纳指科技ETF涨超2%
【ETF动向】8月4日广发中证香港创新药ETF(QDII)基金跌0.07%,份额减少1.42亿份
证券之星 · 08-04
【ETF动向】8月4日广发中证香港创新药ETF(QDII)基金跌0.07%,份额减少1.42亿份
【ETF动向】7月30日汇添富国证港股通创新药ETF基金跌3.11%,份额增加1.91亿份
证券之星 · 07-31
【ETF动向】7月30日汇添富国证港股通创新药ETF基金跌3.11%,份额增加1.91亿份
【ETF动向】7月29日广发中证香港创新药ETF(QDII)基金涨4.42%,份额增加1.96亿份
证券之星 · 07-29
【ETF动向】7月29日广发中证香港创新药ETF(QDII)基金涨4.42%,份额增加1.96亿份
全市场独家品种·创新药ETF天弘(517380)飙涨4.56%,涨幅位居全市场第一
格隆汇 · 07-29
全市场独家品种·创新药ETF天弘(517380)飙涨4.56%,涨幅位居全市场第一
全市场涨幅第一!场内唯一港股通创新药ETF(520880)飙涨3.65%!标的年内涨逾98%
格隆汇 · 07-29
全市场涨幅第一!场内唯一港股通创新药ETF(520880)飙涨3.65%!标的年内涨逾98%
医药板块也“反内卷”!CXO、医疗器械接棒反攻,创新药ETF天弘(517380)、医疗设备ETF(159873)涨超1%
格隆汇 · 07-25
医药板块也“反内卷”!CXO、医疗器械接棒反攻,创新药ETF天弘(517380)、医疗设备ETF(159873)涨超1%
【ETF动向】7月22日广发中证香港创新药ETF(QDII)基金跌0.15%,份额减少2.07亿份
证券之星 · 07-22
【ETF动向】7月22日广发中证香港创新药ETF(QDII)基金跌0.15%,份额减少2.07亿份
汇添富基金乐无穹旗下汇添富国证港股通创新药ETF中报最新持仓,重仓信达生物
证券之星 · 07-20
汇添富基金乐无穹旗下汇添富国证港股通创新药ETF中报最新持仓,重仓信达生物
李茜2025年二季度表现,华泰柏瑞恒生创新药ETF基金季度涨幅20.46%
证券之星 · 07-20
李茜2025年二季度表现,华泰柏瑞恒生创新药ETF基金季度涨幅20.46%
【ETF动向】7月18日广发中证香港创新药ETF(QDII)基金涨0.66%,份额减少7750万份
证券之星 · 07-18
【ETF动向】7月18日广发中证香港创新药ETF(QDII)基金涨0.66%,份额减少7750万份
广发基金刘杰旗下广发中证香港创新药ETF(QDII)中报最新持仓,重仓信达生物
证券之星 · 07-17
广发基金刘杰旗下广发中证香港创新药ETF(QDII)中报最新持仓,重仓信达生物
双靶点减肥药数据亮眼 创新药ETF国泰(517110)配置价值凸显
中国财富通 · 07-17
双靶点减肥药数据亮眼 创新药ETF国泰(517110)配置价值凸显
【ETF动向】7月11日广发中证香港创新药ETF(QDII)基金涨1.34%,份额减少1.93亿份
证券之星 · 07-11
【ETF动向】7月11日广发中证香港创新药ETF(QDII)基金涨1.34%,份额减少1.93亿份
一键配置港股创新药核心资产,港股通创新药ETF嘉实将于7月14日起首发
新浪基金 · 07-11
一键配置港股创新药核心资产,港股通创新药ETF嘉实将于7月14日起首发
加载更多
公司概况
公司名称:
--
所属市场:
上市日期:
--
主营业务:
发行价格:
--
{"stockData":{"symbol":"515120","market":"SH","secType":"STK","nameCN":"创新药ETF","latestPrice":0.676,"timestamp":1754636399000,"preClose":0.677,"halted":0,"volume":359283800,"delay":0,"changeRate":-0.0015,"floatShares":0,"shares":0,"eps":0,"marketStatus":"已收盘","change":-0.001,"latestTime":"08-08 14:59:59","open":0.674,"high":0.679,"low":0.666,"amount":242000000,"amplitude":0.0192,"askPrice":0.676,"askSize":41321,"bidPrice":0.675,"bidSize":8849,"shortable":0,"etf":1,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1754875800000},"marketStatusCode":5,"adr":0,"adjPreClose":0.677,"symbolType":"fund","openAndCloseTimeList":[[1754616600000,1754623800000],[1754629200000,1754636400000]],"highLimit":0.745,"lowLimit":0.609,"ibTradeSell":false,"ibTradeBuySell":true,"isCdr":false,"pbRate":0,"committee":-0.115732,"marketValue":0,"turnoverRate":0,"status":1,"nextConnectDate":"根据港交所公布的数据,今日已停止北向交易,下一个交易日为北京时间 2025-08-11。","floatMarketCap":0},"requestUrl":"/m/hq/s/515120","defaultTab":"news","newsList":[{"id":"2558570390","title":"【ETF动向】8月8日广发中证香港创新药ETF(QDII)基金跌1.33%,份额增加3.8亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2558570390","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558570390?lang=zh_cn&edition=full","pubTime":"2025-08-09 06:30","pubTimestamp":1754692258,"startTime":"0","endTime":"0","summary":"证券之星消息,8月8日,广发中证香港创新药ETF(QDII)基金(513120)跌1.33%,成交额79.16亿元。当日份额增加了3.8亿份,最新份额为122.92亿份,近20个交易日份额增加11.42亿份。当日资金净流入4.2亿元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为172.67亿元。广发中证香港创新药ETF(QDII)基金跟踪标的为中证香港创新药港币指数,成立(2022-07-01)以来超额回报为-35.3%,近一个月超额回报为-0.28%,管理人为广发基金公司,基金经理为刘杰。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025080900005028.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["515120"],"gpt_icon":0},{"id":"2557862534","title":"ETF收评 | A股再创阶段新高,稀土板块爆发,稀土ETF易方达、稀土ETF涨超3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557862534","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557862534?lang=zh_cn&edition=full","pubTime":"2025-08-07 15:11","pubTimestamp":1754550689,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["512710","YANG","BK4585","516780","515890","BK4588","399006","HSCEI","515120","FDN","159883","BK4614","BK1161","512880","510300","159967","399300","BK4550","159992","512510","510880","159713","06978","000300.SH","159982","562600","159715","HSTECH","399001","161024","09996","159562","09997","BK1583","000001.SH","07226","159582","BK1222","516150","BK1100","BK1574","000688.SH","000905.SH"],"gpt_icon":0},{"id":"2557944534","title":"ETF收盘|各ETF跌多涨少 港股通创新药ETF工银跌逾3.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557944534","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557944534?lang=zh_cn&edition=full","pubTime":"2025-08-07 15:05","pubTimestamp":1754550303,"startTime":"0","endTime":"0","summary":"截至收盘,上证指数涨0.16%,创业板指跌0.68%,沪深两市2003只个股上涨,2938只个股下跌。ETF方面,各ETF跌多涨少,稀土ETF易方达、稀有金属ETF、医疗器械ETF基金等涨幅居前,分别涨3.5%、涨2.63%、涨1.99%;港股通创新药ETF工银、科创创新药ETF国泰、港股创新药ETF等跌幅居前,分别跌3.06%、跌3.06%、跌3.05%;短融ETF、银华日利ETF、华宝添益ETF等成交额居前,分别成交247.89亿元、成交204.23亿元、成交179.8亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807150510a6d826a5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807150510a6d826a5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["515120","562800"],"gpt_icon":0},{"id":"2557921583","title":"【ETF动向】8月6日广发中证香港创新药ETF(QDII)基金涨0.75%,份额增加1.38亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2557921583","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557921583?lang=zh_cn&edition=full","pubTime":"2025-08-07 06:30","pubTimestamp":1754519459,"startTime":"0","endTime":"0","summary":"证券之星消息,8月6日,广发中证香港创新药ETF(QDII)基金(513120)涨0.75%,成交额77.68亿元。当日份额增加了1.38亿份,最新份额为113.98亿份,近20个交易日份额减少1.74亿份。当日资金净流入2.27亿元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为167.6亿元。广发中证香港创新药ETF(QDII)基金跟踪标的为中证香港创新药港币指数,成立(2022-07-01)以来超额回报为-37.17%,近一个月超额回报为-0.23%,管理人为广发基金公司,基金经理为刘杰。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025080700003508.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["515120"],"gpt_icon":0},{"id":"2557368773","title":"ETF收评 | 港股创新药板块全天强势,港股创新药ETF、恒生创新药ETF涨3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557368773","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557368773?lang=zh_cn&edition=full","pubTime":"2025-08-05 15:12","pubTimestamp":1754377970,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["515890","000688.SH","513120","399001","512880","NVIW.SI","516630","159659","SQQQ","159992","399006","150227","513090","HSTECH","159982","PSQ","159941","MHGmain","159891","TSYW.SI","000905.SH","MNQmain","510880","515550","515000","NQmain","515120","513100","TQQQ","159732","QQQ","159967","QCmain","YANG","510300","USAW.SI","HSCEI","159315","FDN","06978","000076.SH","03086","000001.SH","HGmain","07226","QLD","399300",".IXIC","512510","USJW.SI"],"gpt_icon":0},{"id":"2557235900","title":"ETF午评 | 隔夜美股收涨,纳指科技ETF涨超2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557235900","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557235900?lang=zh_cn&edition=full","pubTime":"2025-08-05 11:39","pubTimestamp":1754365143,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["159967","159732","159707","515980","515400","000688.SH","399001","YANG","159982","510880","QID","513100","HSCEI","510300","560850","399006","000905.SH","000300.SH",".IXIC","515890","159941","513120","000001.SH","512200","512510","QLD","FDN","TQQQ","USAW.SI","159852","NVIW.SI","512880","515120","SQQQ","159659","07226","QQQ","515000","USJW.SI","TSYW.SI","159992","399300","06978","03086","515230","NQmain","159915","MNQmain","PSQ","HSTECH"],"gpt_icon":0},{"id":"2557833205","title":"【ETF动向】8月4日广发中证香港创新药ETF(QDII)基金跌0.07%,份额减少1.42亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2557833205","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557833205?lang=zh_cn&edition=full","pubTime":"2025-08-05 06:30","pubTimestamp":1754346658,"startTime":"0","endTime":"0","summary":"证券之星消息,8月4日,广发中证香港创新药ETF(QDII)基金(513120)跌0.07%,成交额76.56亿元。当日份额减少了1.42亿份,最新份额为108.65亿份,近20个交易日份额减少8.3亿份。当日资金净流出1.9亿元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为152.57亿元。广发中证香港创新药ETF(QDII)基金跟踪标的为中证香港创新药港币指数,成立(2022-07-01)以来超额回报为-35.66%,近一个月超额回报为-0.32%,管理人为广发基金公司,基金经理为刘杰。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025080500005898.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["515120"],"gpt_icon":0},{"id":"2555507539","title":"【ETF动向】7月30日汇添富国证港股通创新药ETF基金跌3.11%,份额增加1.91亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2555507539","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555507539?lang=zh_cn&edition=full","pubTime":"2025-07-31 08:31","pubTimestamp":1753921893,"startTime":"0","endTime":"0","summary":"证券之星消息,7月30日,汇添富国证港股通创新药ETF基金(159570)跌3.11%,成交额50.18亿元。当日份额增加了1.91亿份,最新份额为61.56亿份,近20个交易日份额增加6.08亿份。当日资金净流入1.17亿元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为119.86亿元。汇添富国证港股通创新药ETF基金跟踪标的为国证港股通创新药指数,成立(2023-12-28)以来超额回报为-32.36%,近一个月超额回报为-0.47%,管理人为汇添富基金公司,基金经理为乐无穹。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025073100006030.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["HSCEI","HSTECH","515120"],"gpt_icon":0},{"id":"2555062521","title":"【ETF动向】7月29日广发中证香港创新药ETF(QDII)基金涨4.42%,份额增加1.96亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2555062521","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555062521?lang=zh_cn&edition=full","pubTime":"2025-07-30 06:31","pubTimestamp":1753828260,"startTime":"0","endTime":"0","summary":"证券之星消息,7月29日,广发中证香港创新药ETF(QDII)基金(513120)涨4.42%,成交额116.41亿元。当日份额增加了1.96亿份,最新份额为108.31亿份,近20个交易日份额减少10.18亿份。当日资金净流入9.84亿元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为161.2亿元。广发中证香港创新药ETF(QDII)基金跟踪标的为中证香港创新药港币指数,成立(2022-07-01)以来超额回报为-37.5%,近一个月超额回报为-0.5%,管理人为广发基金公司,基金经理为刘杰。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025073000004543.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["515120"],"gpt_icon":0},{"id":"2555089512","title":"全市场独家品种·创新药ETF天弘(517380)飙涨4.56%,涨幅位居全市场第一","url":"https://stock-news.laohu8.com/highlight/detail?id=2555089512","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555089512?lang=zh_cn&edition=full","pubTime":"2025-07-29 11:36","pubTimestamp":1753760164,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["IE00B19Z3B42.SGD","159938","BK4532","BK4553","LU1997245094.SGD","BK0060","MU","YANG","GSK","159982","159217","BK0077","LU0719512351.SGD","LU1969619763.USD","GSK.UK","LU0082616367.USD","LU1655091616.SGD","HSCEI","LU1146622755.USD","BK4543","CNHmain","09939","BK0229","FDN","600276","515120","CXO","BK4512","MCNHmain","07226","CYB","603259","159992","399300","CXO.AU","UCmain","03347","LU2286300806.USD","06978","BK0012","02359","300725","LU0405327148.USD","LU1997245177.USD","MUCmain","BK4614","LU1829250122.USD","01276","300347","HSTECH"],"gpt_icon":0},{"id":"2555086517","title":"全市场涨幅第一!场内唯一港股通创新药ETF(520880)飙涨3.65%!标的年内涨逾98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555086517","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555086517?lang=zh_cn&edition=full","pubTime":"2025-07-29 10:43","pubTimestamp":1753757014,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4588","BK1161","BK4550","HSCEI","02833","FDN","HSI","513600","MCHmain","159992","HSImain","BK4585","HSTECH","BK1574","YANG","515120","06978","07226","MHImain","159858","BK4614","HHImain"],"gpt_icon":0},{"id":"2554773796","title":"医药板块也“反内卷”!CXO、医疗器械接棒反攻,创新药ETF天弘(517380)、医疗设备ETF(159873)涨超1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2554773796","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554773796?lang=zh_cn&edition=full","pubTime":"2025-07-25 10:24","pubTimestamp":1753410246,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["03759","515120","300759","300760","02196","HSCEI","000808.SH","159992","603976","CXO","600196","688271","09996","09939","YANG","159399","159645","159891","06178","300122","161726","159859","159883","LU0979878070.USD","HSTECH","163118","688626","06978","09997","159873","159938","159982","603127","399441","07226","159217","BK0060","512290","BK1515","02269","300869","300832","06127","159646","601788","CXO.AU","399300","FDN"],"gpt_icon":0},{"id":"2553696882","title":"【ETF动向】7月22日广发中证香港创新药ETF(QDII)基金跌0.15%,份额减少2.07亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2553696882","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553696882?lang=zh_cn&edition=full","pubTime":"2025-07-23 06:31","pubTimestamp":1753223464,"startTime":"0","endTime":"0","summary":"证券之星消息,7月22日,广发中证香港创新药ETF(QDII)基金(513120)跌0.15%,成交额108.49亿元。当日份额减少了2.07亿份,最新份额为105.92亿份,近20个交易日份额减少8.9亿份。当日资金净流出3.02亿元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为142.68亿元。广发中证香港创新药ETF(QDII)基金跟踪标的为中证香港创新药港币指数,成立(2022-07-01)以来超额回报为-34.17%,近一个月超额回报为-0.78%,管理人为广发基金公司,基金经理为刘杰。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025072300005357.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["515120"],"gpt_icon":0},{"id":"2553441925","title":"汇添富基金乐无穹旗下汇添富国证港股通创新药ETF中报最新持仓,重仓信达生物","url":"https://stock-news.laohu8.com/highlight/detail?id=2553441925","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553441925?lang=zh_cn&edition=full","pubTime":"2025-07-21 07:08","pubTimestamp":1753052913,"startTime":"0","endTime":"0","summary":"证券之星消息,7月21日汇添富基金旗下乐无穹管理的汇添富国证港股通创新药交易型开放式指数基金公布中报,近1年净值增长率122.45%。与上一季度相比,该基金前十大重仓股新增亚盛医药-B;并对信达生物增仓604.75万股,为该基金第一大重仓股;联邦制药等退出前十大重仓股;详细数据如下:以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025072100001482.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["HSTECH","LU1969619763.USD","515120","BK1589","01801","LU2328871848.SGD","BK1583","LU2488822045.USD","BK1161","HSCEI"],"gpt_icon":0},{"id":"2553744196","title":"李茜2025年二季度表现,华泰柏瑞恒生创新药ETF基金季度涨幅20.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2553744196","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553744196?lang=zh_cn&edition=full","pubTime":"2025-07-21 07:06","pubTimestamp":1753052819,"startTime":"0","endTime":"0","summary":"证券之星消息,截止2025年二季度末,基金经理李茜旗下共管理12只基金,本季度表现最佳的为华泰柏瑞恒生创新药ETF,季度净值涨20.46%。持有期间的估算收益率为249.25%,持有期间旗滨集团在2019年到2021年的年报归属净利润增幅达214.96%。持有期间的估算收益率为96.61%,持有期间新易盛在2022年到2023年的年报营业总收入降幅为6.43%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025072100001427.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["515120"],"gpt_icon":0},{"id":"2552189994","title":"【ETF动向】7月18日广发中证香港创新药ETF(QDII)基金涨0.66%,份额减少7750万份","url":"https://stock-news.laohu8.com/highlight/detail?id=2552189994","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552189994?lang=zh_cn&edition=full","pubTime":"2025-07-19 06:30","pubTimestamp":1752877857,"startTime":"0","endTime":"0","summary":"证券之星消息,7月18日,广发中证香港创新药ETF(QDII)基金(513120)涨0.66%,成交额87.66亿元。当日份额减少了7750万份,最新份额为108.19亿份,近20个交易日份额增加1350万份。当日资金净流入4436.99万元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为147.97亿元。广发中证香港创新药ETF(QDII)基金跟踪标的为中证香港创新药港币指数,成立(2022-07-01)以来超额回报为-34.59%,近一个月超额回报为-0.7%,管理人为广发基金公司,基金经理为刘杰。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071900004001.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["515120"],"gpt_icon":0},{"id":"2552342914","title":"广发基金刘杰旗下广发中证香港创新药ETF(QDII)中报最新持仓,重仓信达生物","url":"https://stock-news.laohu8.com/highlight/detail?id=2552342914","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552342914?lang=zh_cn&edition=full","pubTime":"2025-07-18 05:26","pubTimestamp":1752787596,"startTime":"0","endTime":"0","summary":"证券之星消息,7月18日广发基金旗下刘杰管理的广发中证香港创新药交易型开放式指数基金(QDII)公布中报,近1年净值增长率115.66%。其中信达生物持仓占比9.7%,为该基金第一大重仓股;详细数据如下:以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071800003722.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1969619763.USD","LU2328871848.SGD","01801","BK1589","LU2488822045.USD","BK1583","515120","BK1161"],"gpt_icon":0},{"id":"2552709081","title":"双靶点减肥药数据亮眼 创新药ETF国泰(517110)配置价值凸显","url":"https://stock-news.laohu8.com/highlight/detail?id=2552709081","media":"中国财富通","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552709081?lang=zh_cn&edition=full","pubTime":"2025-07-17 12:11","pubTimestamp":1752725474,"startTime":"0","endTime":"0","summary":"7月17日,截至上午收盘,创新药ETF国泰涨幅达2.41%。消息面上,恒瑞医药宣布其GLP-1/GIP双靶点减肥药HRS9531注射液在中国Ⅲ期临床试验中取得积极结果,6mg剂量组平均减重达19.2%,且安全性良好。资料显示,创新药ETF国泰紧密跟踪SHS创新药指数,聚焦创新药研发和生产领域的龙头企业,包括恒瑞医药、百济神州等。市场人士指出,随着双靶点减肥药等创新成果不断涌现,创新药ETF国泰为投资者提供了布局这一高成长赛道的便捷工具。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://irb.cfbond.com/api/v1/detail.html?newsid=3zhsiSu7Vdg%3D","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["515120"],"gpt_icon":0},{"id":"2550896266","title":"【ETF动向】7月11日广发中证香港创新药ETF(QDII)基金涨1.34%,份额减少1.93亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2550896266","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550896266?lang=zh_cn&edition=full","pubTime":"2025-07-12 06:31","pubTimestamp":1752273061,"startTime":"0","endTime":"0","summary":"证券之星消息,7月11日,广发中证香港创新药ETF(QDII)基金(513120)涨1.34%,成交额82.82亿元。当日份额减少了1.93亿份,最新份额为111.49亿份,近20个交易日份额增加11.28亿份。当日资金净流出2454.07万元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为134.08亿元。广发中证香港创新药ETF(QDII)基金跟踪标的为中证香港创新药港币指数,成立(2022-07-01)以来超额回报为-30.04%,近一个月超额回报为-0.42%,管理人为广发基金公司,基金经理为刘杰。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071200005194.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["515120"],"gpt_icon":0},{"id":"2550693292","title":"一键配置港股创新药核心资产,港股通创新药ETF嘉实将于7月14日起首发","url":"https://stock-news.laohu8.com/highlight/detail?id=2550693292","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550693292?lang=zh_cn&edition=full","pubTime":"2025-07-11 18:19","pubTimestamp":1752229140,"startTime":"0","endTime":"0","summary":"在全球医药创新加速、港股市场估值修复的背景下,今年以来,港股创新药板块表现亮眼。Wind数据显示,截至2025年7月8日,中证港股通创新药指数近一年涨幅为107.95%,今年以来涨幅为66.23%,表现显著超越同类创新药指数、A股及港股大盘指数。 根据公告信息,嘉实中证港股通创新药ETF将于7月14日-7月25日公开发售。该产品紧密跟踪中证港股通创新药指数,为投资者一键布局港股创新药龙头企业提供高效便捷的投资工具选择。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/jjh/2025-07-11/doc-inffcark7457260.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["06978","515120","BK4614","YANG","HSTECH","159992","BK1161","BK1574"],"gpt_icon":1}],"profile":{"ret":0,"serverTime":1754711069603,"stockEarnings":[{"period":"1week","weight":-0.016},{"period":"1month","weight":0.1174},{"period":"3month","weight":0.2381},{"period":"6month","weight":0.3025},{"period":"1year","weight":0.4083},{"period":"ytd","weight":0.3}],"compareEarnings":[{"period":"1week","weight":0.0211},{"period":"1month","weight":0.0407},{"period":"3month","weight":0.0877},{"period":"6month","weight":0.1003},{"period":"1year","weight":0.2666},{"period":"ytd","weight":0.0845}],"compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.7","shortVersion":"4.34.7","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"创新药ETF(515120)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供创新药ETF(515120)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"创新药ETF,515120,创新药ETF股票,创新药ETF股票老虎,创新药ETF股票老虎国际,创新药ETF行情,创新药ETF股票行情,创新药ETF股价,创新药ETF股市,创新药ETF股票价格,创新药ETF股票交易,创新药ETF股票购买,创新药ETF股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"创新药ETF(515120)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供创新药ETF(515120)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}